Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 16,72116,740 of 20,252 grants

Active NON-SBIR/STTR RPGS
Stroma penetrating and immune modulating nanoparticles for image-guided therapy of pancreatic cancer
NATIONAL CANCER INSTITUTE Emory University United States 2021 – 2026

Project Summary Resistance to therapy is the major challenge for the treatment of pancreatic cancer. Despite recent successes in immune checkpoint therapy of several human cancer t...

$4.49M
USD
Active NON-SBIR/STTR RPGS
Hexokinase 2 and cancer therapy
NATIONAL CANCER INSTITUTE University of Illinois At Chicago United States 2021 – 2026

Cancer cells are metabolically different from normal matching cells, and this is manifested by the high rate of glucose metabolism in cancer cells. The high rate of glucose metabol...

$5.45M
USD
Active NON-SBIR/STTR RPGS
Targeting p38/JNK MAPK to ameliorate cisplatin-induced adverse sequelae on the nervous system
NATIONAL CANCER INSTITUTE University of California-Irvine United States 2021 – 2026

Chemotherapy-related cognitive impairment (CRCI, chemobrain), chemotherapy-induced peripheral neuropathy (CIPN) and gait changes are debilitating side-effects of cancer treatment w...

$5.75M
USD
Active NON-SBIR/STTR RPGS
Improving the translational value of head and neck cancer patient-in-mouse models
NATIONAL CANCER INSTITUTE University of Wisconsin-Madison United States 2021 – 2026

Project Abstract: Patient-derived model systems are commonly used to study tumor biology and test novel treatments for head and neck cancer. These models are established using pati...

$4.84M
USD
Active NON-SBIR/STTR RPGS
Low Cost Tethered Capsule Endoscope with High-Resolution Digital Chromoscopy for Barrett's Screening
NATIONAL CANCER INSTITUTE Rice University United States 2021 – 2026

Abstract Esophageal cancer is the 6th leading cause of cancer death worldwide; rates of esophageal adenocarcinoma (EAC) haverisen exponentially over the past 4 decades. When EAC is...

$6.07M
USD
Completed OTHER RESEARCH-RELATED
Defining mechanisms of thalidomide analog resistance
NATIONAL CANCER INSTITUTE Brigham and Women'S Hospital United States 2021 – 2025

PROJECT SUMMARY Thalidomide and its analogs, lenalidomide and pomalidomide, have revolutionized the treatment of patients with multiple myeloma (MM) and other hematologic malignanc...

$2.67M
USD
Active NON-SBIR/STTR RPGS
Integrated ligand and target discovery by chemical proteomics for glioblastoma treatment.
NATIONAL CANCER INSTITUTE Stanford University United States 2021 – 2026

PROJECT SUMMARY The epidermal growth factor (EGFR) oncogene is amplified and drives tumor growth in 55% of adult glioblastomas (GBMs). However, EGFR inhibitors have failed to demon...

$6.42M
USD
Active NON-SBIR/STTR RPGS
Discovery and verification of methylated circulating tumor DNA markers for the detection of colorectal cancer in subjects under 50 years of age
NATIONAL CANCER INSTITUTE Cedars-Sinai Medical Center United States 2021 – 2026

Abstract In recent years, the incidence of colorectal cancer (CRC) under the age of 50-years has increased significantly and population-based screening is currently not offered to...

$6.33M
USD
Active NON-SBIR/STTR RPGS
Metabolic Control and Anticancer Mechanism
NATIONAL CANCER INSTITUTE Rutgers Biomedical and Health Sciences United States 2021 – 2027

ABSTRACT As a central controller of cancer growth and metabolism, mTORC1 pathway is commonly mutated and activated in human cancer, leading to uncontrolled growth. Cancer cells are...

$884.9K
USD
Active NON-SBIR/STTR RPGS
Neural Niche in Promoting Brain Metastatic Tumor Progression
NATIONAL CANCER INSTITUTE Ut Southwestern Medical Center United States 2021 – 2026

Project Summary Title: Neural Niche in Promoting Brain Metastasis Progression Metastatic progression at the brain is a multi-step, evolutionary process that is accomplished through...

$4.42M
USD
Completed NON-SBIR/STTR RPGS
High-Throughput Screen for the Oncoprotein MYC
NATIONAL CANCER INSTITUTE Scripps Research Institute, The United States 2021 – 2025

ABSTRACT MYC is a key transcriptional regulator involved in cellular proliferation and has established roles in transcriptional elongation and initiation, microRNA regulation, apop...

$4M
USD
Active NON-SBIR/STTR RPGS
Germline and Somatic Genomic Studies in CLL Minorities
NATIONAL CANCER INSTITUTE Mayo Clinic Rochester United States 2021 – 2026

African Americans are significantly underrepresented in cancer research. Although there have been recent efforts toward more inclusion of African Americans in cancer research, subs...

$6.29M
USD
Active NON-SBIR/STTR RPGS
Epigenetically Engineered Mouse Model for Lung Cancer Therapy
NATIONAL CANCER INSTITUTE Baylor College of Medicine United States 2021 – 2026

PROJECT SUMMARY (Abstract) The importance of aberrant DNA methylation in cancer is clear. The fundamental role of DNA methylation in cancer initiation and progression, however, rem...

$3.43M
USD
Completed NON-SBIR/STTR RPGS
Leveraging Tumor Suppressor Inactivation for Osteosarcoma Therapy
NATIONAL CANCER INSTITUTE Albert Einstein College of Medicine United States 2021 – 2025

PROJECT SUMMARY Osteosarcoma (OS) is the most common malignant bone tumor, found in the pediatric population and often leads to death due to tumor progression and metastasis. Despi...

$4.13M
USD
Active NON-SBIR/STTR RPGS
Genetic dissection of oncogenic Kras signaling
NATIONAL CANCER INSTITUTE Stanford University United States 2021 – 2026

ABSTRACT Lung cancer is a prevalent cancer type that leads to more deaths than the next four major cancer types combined. KRAS is one of the most frequent oncogenes in human lung c...

$4.16M
USD
Active NON-SBIR/STTR RPGS
Using dietary glutamine supplementation for melanoma prevention and targeted therapy
NATIONAL CANCER INSTITUTE University of California-Irvine United States 2021 – 2026

PROJECT SUMMARY Despite recent advances in cancer metabolism, whether and how nutritional interventions affect tumor development, metastasis and therapeutic response are still poor...

$4.04M
USD
Completed OTHER RESEARCH-RELATED
Characterizing Chromatin Remodeling Mechanisms of Chemo-Sensitivity and Resistance in Pediatric Solid Tumors
NATIONAL CANCER INSTITUTE Boston Children'S Hospital United States 2021 – 2025

PROJECT SUMMARY Despite the known roles of chromatin remodeling complexes in driving more than 20% of human cancer, the role of chromatin remodeling complexes in conferring therape...

$1.15M
USD
Active NON-SBIR/STTR RPGS
Regulation of DNA replication kinetics by BRCA2 after DNA damage
NATIONAL CANCER INSTITUTE Rutgers Biomedical and Health Sciences United States 2021 – 2026

Germline mutations in BRCA2 predispose carriers to breast, ovarian, pancreatic, and other cancers. The gene encodes a very large protein that plays critical roles in genome integri...

$3.28M
USD
Completed SBIR-STTR RPGS
VDX-111: A novel targeted therapeutic for triple-negative breast cancer
NATIONAL CANCER INSTITUTE Vona Oncology, Llc United States 2021 – 2025

PROJECT SUMMARY Triple-negative breast cancers (TNBC) represent a significant challenge to basic scientists studying the molecular underpinnings of the disease and to patients and...

$9.95M
USD
Active NON-SBIR/STTR RPGS
Developing novel bispecific antibodies for cancer treatment
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2021 – 2026

PROJECT SUMMARY The overall goal of this project is to improve activities of therapeutic antibodies against cancer metastasis through developing novel bispecific antibodies (BsAbs)...

$5.64M
USD